EUCTR2016-002360-14-DK进行中（未招募）1 期
Phase II trial: PET/CT for staging advanced and localized oral and oropharyngeal cancer
Rigshospitalet, Dapartment of of Clinical Physiology, Nuclear Medicine and PET0 个研究点目标入组 90 人开始时间: 2016年7月27日最近更新:
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Able to understand patient information and to give informed consent
- •Not previously irradiated or operated on neck
- •OSCC or OPSCC cN0 verified histologically by pathologic examination of biopsy
- •OSCC or OPSCC N + verified histologically by pathologic examination of biopsy
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 35
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 55
排除标准
- •Pregnancy
- •Patients who are candidates for curative intentional radiation
- •Patients who have had surgery or radiation therapy to the neck as this may alter the lymph drainage.
- •Other diseases assessed by the investigator as basis for exclusion.
- •Age under 18 or over 85 years
- •Obesity> 140 kg
研究者
相似试验
进行中（未招募）
1 期
uPAR PET/CT og FDG PET/CT til præoperativ stadieinddeling af patienter med nydiagnosticeret Gynækologisk Kræftgynecological cancers:Vulvar cancerendometrial cancer (uterine cancer)cervical cancerovarian cancerMedDRA version: 20.0Level: LLTClassification code 10007107Term: Cancer of ovarySystem Organ Class: 100000021045MedDRA version: 20.0Level: LLTClassification code 10007050Term: CancerSystem Organ Class: 100000020935MedDRA version: 20.0Level: LLTClassification code 10047743Term: Vulval cancer NOSSystem Organ Class: 100000021101MedDRA version: 20.0Level: LLTClassification code 10007063Term: Cancer of endometriumSystem Organ Class: 100000021008MedDRA version: 20.0Level: LLTClassification code 10008229Term: Cervical cancerSystem Organ Class: 100000020977EUCTR2016-004638-99-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET350
已完成
2 期
A clinical trial to see whether outcomes in Hodgkins Lymphoma can be improved by using increased intensity therapy in interim PET scan positive patientsCTRI/2012/06/002741Cancer Institute50
进行中（未招募）
1 期
Phase II trial: uPAR PET/CT and FDG PET/MRI for determining lymph node metastases in patients with bladder cancerrinary bladder cancerMedDRA version: 19.0Level: LLTClassification code 10005004Term: Bladder cancer NOSSystem Organ Class: 100000004864EUCTR2016-001026-33-DKRigshospitalet, Department of Clinical Physiology, Nuclear Medicine and PET40
进行中（未招募）
1 期
uPAR-PET - a new method for determining lymph node metastases in breast cancer patientsMedDRA version: 18.1Level: LLTClassification code 10006192Term: Breast cancer NOSSystem Organ Class: 100000004864breast cancerEUCTR2015-004503-23-DKRigshospitalet, Department of Clinical Physiology, Nucelar Medicine and PET
进行中（未招募）
2 期
Pertuzumab and Trastuzumab as Neoadjuvant Treatment in Patients With HER2-Positive Breast CancerBreast CancerNCT01937117Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins88